; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (161) Fluopyram and trifloxystrobin formulations Heading 9902.09.55 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl} acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (162) Trifloxystrobin formulations Heading 9902.09.57 is amended— (A) by amending the article description to read as follows: Product mixtures containing methyl (2E)-(methoxyimino)[2-({[(E)-{1-[3-(trifluoromethyl) phenyl] ethylidene}amino]oxy}methyl)phenyl]acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (163) Fluopyram and prothioconazole formulations Heading 9902.09.58 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and (RS)-2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl] -2,4-dihydro-1,2,4-triazole-3-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (164) Prothioconazole formulations Heading 9902.09.59 is amended— (A) by amending the article description to read as follows: Product mixtures containing 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl] -1,2-dihydro-3H-1,2,4-triazole-3-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15)